Pivotal Trials for Applications for ctDNA as Agnostics & End Points for Patient Stratification & Treatment Response Assessment
Time: 8:30 am
day: Day Two
Details:
• Showcasing working projects and publications
• What it takes to develop a profile to deliver the data package to achieve proof of concept
• Combining and co-developing tests and drugs to bring forward to market
• New ways to define patient populations and disease especially in lung cancer
